Posts tagged science
Articles and news from the latest research reports.
It may be the stuff of science fiction but this is real, on the 21st of June 2014 at Arena Corinthians in São Paulo, during the opening ceremony of the World Cup 2014, a paraplegic Brazilian teenager will stand up out of his wheelchair, walk to the central circle and kick a football. What will allow the boy to do this is a mind-controlled robotic exoskeleton developed over years of collaboration by an international team of scientists on the Walk Again project.
Read more: Robotic suit to kick off World Cup 2014
Autism rates have skyrocketed in recent years, according to recent data from the Centers for Disease Control. Much of that has to do with our growing awareness of the disorder. But despite what we are learning about the possible origins and causes of autism, which has no cure, it continues to frustrate and perplex.
In honor of Autism Awareness Month, we’ve compiled a list of longform journalism pieces that give glimpses into the world of those diagnosed with the disorder, and the struggle of those who love and care for them. In one, a father figures out the secret to connecting with his autistic son. In another, we meet the first person ever diagnosed with the disorder. Bookmark these four deep dives into the world of autism, and take your time to read them throughout the month.
“Reaching My Autistic Son Through Disney,” The New York Times Magazine
“Catch Me If You Can,” Outside
“Navigating Love and Autism,” The New York Times
“Autism’s First Child,” The Atlantic
Tweeting a killer migraine in real time
Not even the pain of a migraine headache keeps people from Twitter.
Over the course of a week, students collected every tweet that mentioned the word migraine. Once they cleared out the ads, the retweets and the metaphorical uses of the word, they had 14,028 tweets from people who described their migraine headaches in real time — with words such as “killer,” “the worst” (almost 15% of the tweets) and the F-word.
The Twitter users also reported the repercussions from their migraines: missing school or work, lost sleep, mood changes.
The researchers found the information to be “a powerful source of knowledge” about the headaches, because usually sufferers are providing information after the fact in clinical situations.
“The technology evolves, and our language evolves,” Dr. Alexandre DaSilva, an assistant professor at the University of Michigan School of Dentistry and lead author of the study, said Wednesday by phone. Clinical researchers’ language — such as “throbbing” or “pulsating” — might not be as apt today, to “the generation that grew up with video games.”
Key chocolate ingredients could help prevent obesity, diabetes
Improved thinking. Decreased appetite. Lowered blood pressure. The potential health benefits of dark chocolate keep piling up, and scientists are now homing in on what ingredients in chocolate might help prevent obesity, as well as type-2 diabetes. They found that one particular type of antioxidant in cocoa prevented laboratory mice from gaining excess weight and lowered their blood sugar levels. The report appears in ACS’ Journal of Agricultural & Food Chemistry.
Andrew P. Neilson and colleagues explain that cocoa, the basic ingredient of chocolate, is one of the most flavanol-rich foods around. That’s good for chocolate lovers because previous research has shown that flavanols in other foods such as grapes and tea can help fight weight gain and type-2 diabetes. But not all flavanols, which are a type of antioxidant, are created equal. Cocoa has several different kinds of these compounds, so Neilson’s team decided to tease them apart and test each individually for health benefits.
The scientists fed groups of mice different diets, including high-fat and low-fat diets, and high-fat diets supplemented with different kinds of flavanols. They found that adding one particular set of these compounds, known as oligomeric procyanidins (PCs), to the food made the biggest difference in keeping the mice’s weight down if they were on high-fat diets. They also improved glucose tolerance, which could potentially help prevent type-2 diabetes. “Oligomeric PCs appear to possess the greatest antiobesity and antidiabetic bioactivities of the flavanols in cocoa, particularly at the low doses employed for the present study,” the researchers state.
(Source: acs.org)
Oxytocin, the ‘love’ hormone, promotes group lying
According to a new study by researchers at Ben-Gurion University of the Negev (BGU) and the University of Amsterdam, oxytocin caused participants to lie more to benefit their groups, and to do so more quickly and without expectation of reciprocal dishonesty from their group. Oxytocin is a hormone the body naturally produces to stimulate bonding.
The research was published this week in the Proceedings of the National Academy of Science (PNAS).
"Our results suggest people are willing to bend ethical rules to help the people close to us, like our team or family," says Dr. Shaul Shalvi of Ben-Gurion University of the Negev’s Department of Psychology and director of BGU’s Center for Decision Making and Economic Psychology. "This raises an interesting, although perhaps more philosophical, question: Are all lies immoral?"
Dr. Shalvi’s research focuses on ethical decision-making and the justifications people use to do wrong and still feel moral. Specifically, he looks at what determines how much people lie and which settings increase people’s honesty. Very little is known about the biological foundations of immoral behavior.
"Together, these findings fit a functional perspective on morality revealing dishonesty to be plastic and rooted in evolved neurobiological circuitries, and align with work showing that oxytocin shifts the decision-maker’s focus from self to group interests," Shalvi says.
"The results highlight the role of bonding and cooperation in shaping dishonesty, providing insight into when and why collaboration turns into corruption."
Oxytocin is a peptide of nine amino acids produced in the brain’s hypothalamus, functioning as both a hormone and neurotransmitter. Research has shown that in addition to its bonding effect in couples and between mothers and babies, it also stimulates one’s social approach.
Higher levels of oxytocin correlate with greater empathy, lower social anxiety and more pro-social choice in anonymous games; reduction in fear response; and greater trust in interpersonal exchange. It also stimulates defense-related aggression.
In the experiment designed by Shalvi and fellow researcher Carsten K. W. De Dreu of the University of Amsterdam’s Department of Psychology, 60 male participants received an intranasal dose of either oxytocin or placebo. They were then split into teams of three and asked to predict the results of 10 coin tosses.
Participants were asked to toss the coin, see the outcome and report whether their prediction was correct. They knew that for each correct prediction, they could lie and earn more money to split between their group members, who were engaging in the same task.
"The statistical probability of someone correctly guessing the results of nine or 10 coin tosses is about one percent," says Shalvi. "Yet, 53 percent of those who were given oxytocin claimed to have correctly predicted that many coin tosses, which is extremely unlikely."
Only 23 percent of the participants who received the placebo reported the same results, reflecting a high likelihood that they were also lying, but to a lesser extent compared to those receiving oxytocin.
(Source: eurekalert.org)
First UK study of ketamine for people with severe depression
The first UK study of the use of ketamine intravenous infusions in people with treatment-resistant depression has been carried out in an NHS clinic by researchers at Oxford Health NHS Foundation Trust and the University of Oxford.
'Ketamine is a promising new antidepressant which works in a different way to existing antidepressants. We wanted to see whether it would be safe if given repeatedly, and whether it would be practical in an NHS setting. We especially wanted to check that repeated infusions didn't cause cognitive problems,' explains principal investigator Dr Rupert McShane, a consultant psychiatrist at Oxford Health and a researcher in Oxford University's Department of Psychiatry.
The researchers confirmed that ketamine has a rapid antidepressant effect in some patients with severe depression who have not responded to other treatments. These are patients suffering from severe depression which may have lasted years despite multiple antidepressants and talking therapies. Although many patients relapsed within a day or two, 29% had benefit which lasted at least three weeks and 15% took over two months to relapse.
Ketamine did not cause cognitive or bladder side effects when given on up to six occasions, although some people did experience other side effects such as anxiety during the infusion or being sick. The team have now given over 400 infusions to 45 patients and are exploring ways to maintain the effect. They report their findings in the Journal of Psychopharmacology. The study was funded by National Institute for Health Research (NIHR) Research for Patient Benefit Programme.
Schizophrenia: What’s in my head?
When she’s experiencing hallucinations, artist Sue Morgan feels compelled to draw; to ‘get it out of her head’. Sue was diagnosed with schizophrenia about 20 years ago. The drawing is therapeutic, but it’s also Sue’s way of expressing the complex and sometimes frightening secret world in her head. In this film Sue meets Sukhi Shergill, a clinician and researcher at the Institute of Psychiatry in London. He’s also making pictures, but using MRI to peer inside the brains of schizophrenia patients.
Read more about schizophrenia
Forget Smart Watches, ‘Smart Skin’ May Be the Next Big Thing in Wearable Computers
Parkinson’s patients could one day ditch their pills for a stretchy skin patch with a mind of its own. Using specialized sensors, the patch would monitor the wearer’s vital signs, beam the information to a doctor, and administer medication as needed. While such devices still face substantial obstacles before wide-scale implementation, two teams of researchers have announced innovations combining standard electronics with flexible materials that may bring the futuristic concept closer to reality.
Conventional electronics, such as those found in computers and smartphones, are built on stiff slabs of silicon. While durable, the design makes for bulky and uncomfortable wearable devices. Flexible electronics instead print circuits onto limber strips of silicone or plastic. The bendable base layers make devices twist and stretch when attached to the skin, but they are limited by a lack of key components such as batteries and processors that currently do not exist in flexible form.
Researchers from Seoul National University led by bioengineer Dae-Hyeong Kim have now developed a patch that automatically delivers medication to Parkinson’s patients. Parkinson’s disease is a neurological disorder that causes movement impairments such as hand tremors that require regular medication to suppress. Typically, patients take pills every few hours, leading to a spike in medication levels followed by a gradual decline that causes the tremors to return. The team’s skin patch instead supplies a series of smaller measured doses as needed by using a tremor-detecting sensor. Because the device needs to track the tremors over time, they utilized a newly invented memory format called resistive random-access memory to create the first flexible data storage for wearable devices. The new format can be used in a thin, low-power form, making it ideal for inclusion in wearable electronics.
Toward a clearer diagnosis of chronic fatigue syndrome
Chronic fatigue syndrome, which is also known as myalgic encephalomyelitis, is a debilitating condition characterized by chronic, profound, and disabling fatigue. Unfortunately, the causes are not well understood.
Neuroinflammation—the inflammation of nerve cells—has been hypothesized to be a cause of the condition, but no clear evidence has been put forth to support this idea. Now, in this clinically important study, published in the Journal of Nuclear Medicine, the researchers found that indeed the levels of neuroinflammation markers are elevated in CFS/ME patients compared to the healthy controls.
The researchers performed PET scanning on nine people diagnosed with CFS/ME and ten healthy people, and asked them to complete a questionnaire describing their levels of fatigue, cognitive impairment, pain, and depression. For the PET scan they used a protein that is expressed by microglia and astrocyte cells, which are known to be active in neuroinflammation.
The researchers found that neuroinflammation is higher in CFS/ME patients than in healthy people. They also found that inflammation in certain areas of the brain—the cingulate cortex, hippocampus, amygdala, thalamus, midbrain, and pons—was elevated in a way that correlated with the symptoms, so that for instance, patients who reported impaired cognition tended to demonstrate neuroinflammation in the amygdala, which is known to be involved in cognition. This provides clear evidence of the association between neuroinflammation and the symptoms experienced by patients with CFS/ME.
Though the study was a small one, confirmation of the concept that PET scanning could be used as an objective test for CFS/ME could lead to better diagnosis and ultimately to the development of new therapies to provide relief to the many people around the world afflicted by this condition. Dr. Yasuyoshi Watanabe, who led the study at RIKEN, stated, “We plan to continue research following this exciting discovery in order to develop objective tests for CFS/ME and ultimately ways to cure and prevent this debilitating disease.”